Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Pancreatic Ductal Adenocarcinoma × Pancreaticoduodenectomy × Clear all

Phase

Status

Unknown 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Pancreatic Neoplasms 17 Pancreatic Fistula 3 Gastroparesis 2 Bile Duct Neoplasms 2 Recurrence 1 Pancreatitis, Chronic 1 Pancreatic Ductal Adenocarcinoma 1 Non-alcoholic Fatty Liver Disease 1 Jaundice, Obstructive 1 Hypoxia 1 Hemorrhage 1 Fatty Liver 1 Cholangiocarcinoma 1 Carcinoma, Pancreatic Ductal 1

Interventions

tislelizumab 1 lenvatinib 1 Positron Emission Tomography Computed Tomography 1 Pancreaticoduodenectomy 1 Electroporation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02787187 2021-11-23

Lymphadenectomy for Pancreatic Head Cancer: Standard or Extended?

Ruijin Hospital

Phase NA Completed

Gastrointestinal

Pancreatic Ductal Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡